Physician profile
James K Joyce
NPI 1922291905
$1,384.49
in general payments reported to CMS, 2019-2025
15 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.32 · 2020: $208 · 2021: $157 · 2022: $170 · 2023: $413 · 2024: $223 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $523.07 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $333.79 | 2020-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.29 | 2023-2025 | Xifaxan |
| Paratek Pharmaceuticals, INC. | $70.16 | 2022-2024 | Nuzyra |
| Stryker Corporation | $64.79 | 2025 | Clottriever Bold Catheter, Flowtriever |
| Ceribell, INC. | $35.09 | 2025 | Pocket Eeg Device |
| Gilead Sciences, INC. | $34.30 | 2023 | Veklury |
| Inari Medical, INC. | $27.62 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $26.69 | 2021-2023 | Farxiga |
| Metacel Pharmaceuticals LLC | $24.91 | 2022 | |
| Vifor Pharma, INC. | $23.39 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $23.13 | 2021 | |
| Baxter Healthcare | $18.89 | 2023 | Hillrom - Life 2000 Ventilation System |
| Otsuka America Pharmaceutical, INC. | $17.20 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $16.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Joyce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.